Particle Therapy Market

Particle Therapy Market (Therapy - Proton Therapy, Carbon Therapy, Other Therapy; Cancer Application - Pediatric Cancer, Lung Cancer, Bladder Cancer, Brain and Spinal Cord Tumors (BSCT), Breast Cancer, Gastrointestinal (GI) Cancers, Hepatocellular Carcinoma (HCC), Head and Neck Cancers (HNC); Services - Cyclotrons, Synchrotrons, Synchrocyclotrons; End user - Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL56133
  • Published On : Feb 2019
  • No. of Pages : 230
  • Category : Healthcare

1. Preface
   1.1. Market Definition and Scope
   1.2. Market Segmentation
   1.3. Key Research Objectives
   1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Particle Therapy Market

4. Market Overview
   4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution / Developments
   4.2. Overview
   4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
   4.4. Global Particle Therapy Market Analysis and Forecast, 2016–2026
        4.4.1. Market Revenue Projections (US$ Mn)
   4.5. Market Outlook
   4.6. Regulatory Scenarios
   4.7. Particle therapy facilities in clinical operation, 2017
   4.8. Pricing Analysis, 2017

5. Global Particle Therapy Market Analysis and Forecast, by Therapy
   5.1. Introduction & Definition
   5.2. Key Findings / Developments
   5.3. Global Particle Therapy Market Forecast, by Therapy, 2016–2026
        5.3.1. Photon Therapy
        5.3.2. Carbon Therapy
        5.3.3. Other Therapy
   5.4. Global Particle Therapy Market Attractiveness, by Therapy

6. Global Particle Therapy Market Analysis and Forecast, by Cancer Application
   6.1. Introduction & Definition
   6.2. Key Findings / Developments
   6.3. Global Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        6.3.1. Pediatric Cancer
        6.3.2. Lung Cancer
        6.3.3. Bladder Cancer
        6.3.4. Brain and Spinal Cord Tumors (BSCT)
        6.3.5. Breast Cancer
        6.3.6. Gastrointestinal (GI) Cancers
        6.3.7. Hepatocellular Carcinoma (HCC)
        6.3.8. Head and Neck Cancers (HNC)
        6.3.9. Others
   6.4. Global Particle Therapy Market Attractiveness, by Cancer Application

7. Global Particle Therapy Market Analysis and Forecast, by Services
   7.1. Introduction & Definition
   7.2. Key Findings / Developments
   7.3. Global Particle Therapy Market Forecast, by Services, 2016–2026
        7.3.1. Cyclotrons
        7.3.2. Synchrotrons
        7.3.3. Synchrocyclotrons
   7.4. Global Particle Therapy Market Attractiveness, by Services

8. Global Particle Therapy Market Analysis and Forecast, by End-user
   8.1. Introduction & Definition
   8.2. Key Findings / Developments
   8.3. Global Particle Therapy Market Forecast, by End-user, 2016–2026
        8.3.1. Hospitals
        8.3.2. Specialty Clinics
        8.3.3. Ambulatory Surgical Centers
        8.3.4. Others
   8.4. Global Particle Therapy Market Attractiveness, by End-user

9. Global Particle Therapy Market Analysis and Forecast, by Region
   9.1. Key Findings
   9.2. Market Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
   9.3. Global Particle Therapy Market Attractiveness, by Region

10. North America Particle Therapy Market Analysis and Forecast
   10.1.Introduction
        10.1.1. Key Findings
   10.2. North America Particle Therapy Market Forecast, by Therapy, 2016–2026
        10.2.1. Photon Therapy
        10.2.2. Carbon Therapy
        10.2.3. Other Therapy
   10.3. North America Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        10.3.1. Pediatric Cancer
        10.3.2. Lung Cancer
        10.3.3. Bladder Cancer
        10.3.4. Brain and Spinal Cord Tumors (BSCT)
        10.3.5. Breast Cancer
        10.3.6. Gastrointestinal (GI) Cancers
        10.3.7. Hepatocellular Carcinoma (HCC)
        10.3.8. Head and Neck Cancers (HNC)
        10.3.9. Others
   10.4. North America Particle Therapy Market Forecast, by Services, 2016–2026
        10.4.1. Cyclotrons
        10.4.2. Synchrotrons
        10.4.3. Synchrocyclotrons
   10.5. North America Particle Therapy Market Forecast, by End-user, 2016–2026
        10.5.1. Hospitals
        10.5.2. Specialty Clinics
        10.5.3. Ambulatory Surgical Centers
        10.5.4. Others
   10.6. North America Particle Therapy Market Forecast, by Country, 2016–2026
        10.6.1. U.S.
        10.6.2. Canada
   10.7. North America Particle Therapy Market Attractiveness Analysis
        10.7.1. By Therapy
        10.7.2. By Cancer Application
        10.7.3. By Services
        10.7.4. By End-user
        10.7.5. By Country

11. Europe Particle Therapy Market Analysis and Forecast
   11.1.Introduction
        11.1.1. Key Findings
   11.2. Europe Particle Therapy Market Forecast, by Therapy, 2016–2026
        11.2.1. Photon Therapy
        11.2.2. Carbon Therapy
        11.2.3. Other Therapy
   11.3. Europe Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        11.3.1. Pediatric Cancer
        11.3.2. Lung Cancer
        11.3.3. Bladder Cancer
        11.3.4. Brain and Spinal Cord Tumors (BSCT)
        11.3.5. Breast Cancer
        11.3.6. Gastrointestinal (GI) Cancers
        11.3.7. Hepatocellular Carcinoma (HCC)
        11.3.8. Head and Neck Cancers (HNC)
        11.3.9. Others
   11.4. Europe Particle Therapy Market Forecast, by Services, 2016–2026
        11.4.1. Cyclotrons
        11.4.2. Synchrotrons
        11.4.3. Synchrocyclotrons
   11.5. Europe Particle Therapy Market Forecast, by End-user, 2016–2026
        11.5.1. Hospitals
        11.5.2. Specialty Clinics
        11.5.3. Ambulatory Surgical Centers
        11.5.4. Others
   11.6. Europe Particle Therapy Market Forecast, by Country/Sub-region, 2016–2026
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Spain
        11.6.5. Italy
        11.6.6. Rest of Europe
   11.7. Europe Particle Therapy Market Attractiveness Analysis
        11.7.1. By Therapy
        11.7.2. By Cancer Application
        11.7.3. By Services
        11.7.4. By End-user
        11.7.5. By Country/Sub-region

12. Asia Pacific Particle Therapy Market Analysis and Forecast
   12.1.Introduction
        12.1.1. Key Findings
   12.2. Asia Pacific Particle Therapy Market Forecast, by Therapy, 2016–2026
        12.2.1. Photon Therapy
        12.2.2. Carbon Therapy
        12.2.3. Other Therapy
   12.3. Asia Pacific Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        12.3.1. Pediatric Cancer
        12.3.2. Lung Cancer
        12.3.3. Bladder Cancer
        12.3.4. Brain and Spinal Cord Tumors (BSCT)
        12.3.5. Breast Cancer
        12.3.6. Gastrointestinal (GI) Cancers
        12.3.7. Hepatocellular Carcinoma (HCC)
        12.3.8. Head and Neck Cancers (HNC)
        12.3.9. Others
   12.4. Asia Pacific Particle Therapy Market Forecast, by Services, 2016–2026
        12.4.1. Cyclotrons
        12.4.2. Synchrotrons
        12.4.3. Synchrocyclotrons
   12.5. Asia Pacific Particle Therapy Market Forecast, by End-user, 2016–2026
        12.5.1. Hospitals
        12.5.2. Specialty Clinics
        12.5.3. Ambulatory Surgical Centers
        12.5.4. Others
   12.6. Asia Pacific Particle Therapy Market Forecast, by Country/Sub-region, 2016–2026
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
   12.7. Asia Pacific Particle Therapy Market Attractiveness Analysis
        12.7.1. By Therapy
        12.7.2. By Cancer Application
        12.7.3. By Services
        12.7.4. By End-user
        12.7.5. By Country/Sub-region

13. Latin America Particle Therapy Market Analysis and Forecast
   13.1.Introduction
        13.1.1. Key Findings
   13.2. Latin America Particle Therapy Market Forecast, by Therapy, 2016–2026
        13.2.1. Photon Therapy
        13.2.2. Carbon Therapy
        13.2.3. Other Therapy
   13.3. Latin America Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        13.3.1. Pediatric Cancer
        13.3.2. Lung Cancer
        13.3.3. Bladder Cancer
        13.3.4. Brain and Spinal Cord Tumors (BSCT)
        13.3.5. Breast Cancer
        13.3.6. Gastrointestinal (GI) Cancers
        13.3.7. Hepatocellular Carcinoma (HCC)
        13.3.8. Head and Neck Cancers (HNC)
        13.3.9. Others
   13.4. Latin America Particle Therapy Market Forecast, by Services, 2016–2026
        13.4.1. Cyclotrons
        13.4.2. Synchrotrons
        13.4.3. Synchrocyclotrons
   13.5. Latin America Particle Therapy Market Forecast, by End-user, 2016–2026
        13.5.1. Hospitals
        13.5.2. Specialty Clinics
        13.5.3. Ambulatory Surgical Centers
        13.5.4. Others
   13.6. Latin America Particle Therapy Market Forecast, by Country/Sub-region, 2016–2026
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
   13.7. Latin America Particle Therapy Market Attractiveness Analysis
        13.7.1. By Therapy
        13.7.2. By Cancer Application
        13.7.3. By Services
        13.7.4. By End-user
        13.7.5. By Country/Sub-region

14. Middle East & Africa Particle Therapy Market Analysis and Forecast
   14.1.Introduction
        14.1.1. Key Findings
   14.2. Middle East & Africa Particle Therapy Market Forecast, by Therapy, 2016–2026
        14.2.1. Photon Therapy
        14.2.2. Carbon Therapy
        14.2.3. Other Therapy
   14.3. Middle East & Africa Particle Therapy Market Forecast, by Cancer Application, 2016–2026
        14.3.1. Pediatric Cancer
        14.3.2. Lung Cancer
        14.3.3. Bladder Cancer
        14.3.4. Brain and Spinal Cord Tumors (BSCT)
        14.3.5. Breast Cancer
        14.3.6. Gastrointestinal (GI) Cancers
        14.3.7. Hepatocellular Carcinoma (HCC)
        14.3.8. Head and Neck Cancers (HNC)
        14.3.9. Others
   14.4. Middle East & Africa Particle Therapy Market Forecast, by Services, 2016–2026
        14.4.1. Cyclotrons
        14.4.2. Synchrotrons
        14.4.3. Synchrocyclotrons
   14.5. Middle East & Africa Particle Therapy Market Forecast, by End-user, 2016–2026
        14.5.1. Hospitals
        14.5.2. Specialty Clinics
        14.5.3. Ambulatory Surgical Centers
        14.5.4. Others
   14.6. Middle East & Africa Particle Therapy Market Forecast, by Country/Sub-region, 2016–2026
        14.6.1. GCC countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
   14.7. Middle East & Africa Particle Therapy Market Attractiveness Analysis
        14.7.1. By Therapy
        14.7.2. By Cancer Application
        14.7.3. By Services
        14.7.4. By End-user
        14.7.5. By Country/Sub-region

15. Competition Landscape
   15.1.Market Player – Competition Matrix (By Tier and Size of companies)
   15.2.Market Share Analysis By Company (2017)
   15.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
        15.3.1. Varian Medical Systems, Inc.
               15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.1.2. Product Portfolio
               15.3.1.3. SWOT Analysis
               15.3.1.4. Financial Overview
               15.3.1.5. Strategic Overview
        15.3.2. Hitachi, Ltd.
               15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.2.2. Product Portfolio
               15.3.2.3. SWOT Analysis
               15.3.2.4. Financial Overview
               15.3.2.5. Strategic Overview
        15.3.3. IBA Worldwide
               15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.3.2. Product Portfolio
               15.3.3.3. SWOT Analysis
               15.3.3.4. Financial Overview
               15.3.3.5. Strategic Overview
        15.3.4. Advanced Oncotherapy PLC.
               15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.4.2. Product Portfolio
               15.3.4.3. SWOT Analysis
               15.3.4.4. Financial Overview
               15.3.4.5. Strategic Overview
        15.3.5. Mevion Medical Systems, Inc.
               15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.5.2. Product Portfolio
               15.3.5.3. SWOT Analysis
               15.3.5.4. Financial Overview
               15.3.5.5. Strategic Overview
        15.3.6. Danfysik A/S
               15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.6.2. Product Portfolio
               15.3.6.3. SWOT Analysis
               15.3.6.4. Financial Overview
               15.3.6.5. Strategic Overview
        15.3.7. Sumitomo Heavy Industries, Ltd.
               15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.7.2. Product Portfolio
               15.3.7.3. SWOT Analysis
               15.3.7.4. Financial Overview
               15.3.7.5. Strategic Overview
        15.3.8. Optivus Proton Therapy, Inc.
               15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.8.2. Product Portfolio
               15.3.8.3. SWOT Analysis
               15.3.8.4. Financial Overview
               15.3.8.5. Strategic Overview
        15.3.9. Protom International, Inc.
               15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
               15.3.9.2. Product Portfolio
               15.3.9.3. SWOT Analysis
               15.3.9.4. Financial Overview
               15.3.9.5. Strategic Overview
        15.3.10. Others

List of Tables

Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016–2026
Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 08: North America Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 13: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016–2026
Table 15: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 18: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016–2026
Table 20: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 22: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 23: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016–2026
Table 25: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016–2026
Table 27: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016–2026
Table 28: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 29: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016–2026

List of Figures

Figure 01: Global Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 02: Global Particle Therapy Market Value Share, by Cancer Application, 2017
Figure 03: Global Particle Therapy Market Value Share, by Services, 2017
Figure 04: Global Particle Therapy Market Value Share, by End-user, 2017
Figure 05: Global Particle Therapy Market Value Share, by Region, 2017
Figure 06: Global Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 07: Global Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 08: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Proton Therapy, 2016–2026
Figure 09: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Carbon Therapy, 2016–2026
Figure 10: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Therapy, 2016–2026
Figure 11: Global Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 12: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pediatric Cancer, 2016–2026
Figure 13: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lung Cancer, 2016–2026
Figure 14: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bladder Cancer, 2016–2026
Figure 15: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Brain and Spinal Cord Tumors (BSCT), 2016–2026
Figure 16: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Breast Cancer, 2016–2026
Figure 17: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal (GI) Cancers, 2016–2026
Figure 18: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hepatocellular Carcinoma (HCC), 2016–2026
Figure 19: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Head and Neck Cancers (HNC), 2016–2026
Figure 20: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Cancers, 2016–2026
Figure 21: Global Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 22: Global Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 23: Global Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 24: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cyclotrons, 2016–2026
Figure 25: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Synchrotrons, 2016–2026
Figure 26: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Synchrocyclotrons, 2016–2026
Figure 27: Global Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 28: Global Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 29: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
Figure 30: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics, 2016–2026
Figure 31: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2016–2026
Figure 32: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 33: Global Particle Therapy Market Value Share, by Region, 2018 and 2026
Figure 34: Global Particle Therapy Market Attractiveness, by Region, 2018–2026
Figure 35: North America Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 36: North America Particle Therapy Market Value Share, by Country, 2018–2026
Figure 37: North America Particle Therapy Market Attractiveness, by Country, 2018–2026
Figure 38: North America Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 39: North America Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 40: North America Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 41: North America Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 42: North America Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 43: North America Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 44: North America Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 45: North America Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 46: Europe Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 47: Europe Particle Therapy Market Value Share, by Country/Sub-Region, 2018–2026
Figure 48: Europe Particle Therapy Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 49: Europe Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 50: Europe Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 51: Europe Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 52: Europe Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 53: Europe Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 54: Europe Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 55: Europe Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 56: Europe Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 57: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 58: Asia Pacific Particle Therapy Market Value Share, by Country/Sub-Region, 2018–2026
Figure 59: Asia Pacific Particle Therapy Market Attractiveness, by Country, 2018–2026
Figure 60: Asia Pacific Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 61: Asia Pacific Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 62: Asia Pacific Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 63: Asia Pacific Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 64: Asia Pacific Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 65: Asia Pacific Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 66: Asia Pacific Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 67: Asia Pacific Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 68: Latin America Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 69: Latin America Particle Therapy Market Value Share, by Country/Sub-Region, 2018–2026
Figure 70: Latin America Particle Therapy Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 71: Latin America Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 72: Latin America Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 73: Latin America Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 74: Latin America Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 75: Latin America Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 76: Latin America Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 77: Latin America Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 78: Latin America Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 79: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 80: Middle East & Africa Particle Therapy Market Value Share, by Country/Sub-region, 2018 and 2026
Figure 81: Middle East & Africa Particle Therapy Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 82: Middle East & Africa Particle Therapy Market Value Share, by Therapy, 2018 and 2026
Figure 83: Middle East & Africa Particle Therapy Market Attractiveness, by Therapy, 2018–2026
Figure 84: Middle East & Africa Particle Therapy Market Value Share, by Services, 2018 and 2026
Figure 85: Middle East & Africa Particle Therapy Market Attractiveness, by Services, 2018–2026
Figure 86: Middle East & Africa Particle Therapy Market Value Share, by End-user, 2018 and 2026
Figure 87: Middle East & Africa Particle Therapy Market Attractiveness, by End-user, 2018–2026
Figure 88: Middle East & Africa Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
Figure 89: Middle East & Africa Particle Therapy Market Attractiveness, by Cancer Application, 2018–2026
Figure 90: Global Particle Therapy Market Share, by Company, 2017

.